News & events
Interim report January - March 2026
NOTICE OF ANNUAL GENERAL MEETING IN Q-LINEA AB (PUBL)
The shareholders in Q-linea AB (publ), reg. no. 556729-0217 (the “Company”) are hereby convened to the annual general meeting...
Read more >
Q-linea publish the Annual report for 2025
Q-linea AB (publ) (Nasdaq Stockholm: QLINEA), announced today that the Annual Report for the 2025 fiscal year has been...
Read more >
Q-linea announces FDA clearance of expanded ASTar blood testing menu
Q-linea AB (publ) (OMX: QLINEA) today announces the company has received 510(k) clearance from the US FDA for its...
Read more >
The nomination committee's proposals to Q-linea’s annual general meeting 2026
The nomination committee of Q-linea AB (publ) (Nasdaq Stockholm: QLINEA) has submitted its proposals to Q-linea´s annual general meeting...
Read more >
Year-end report 1 January – 31 December 2025
A solid foundation laid for a successful 2026The quarter October – December 2025• Net sales amounted to SEK 2.9 (0.2)...
Read more >
Load more